Berberine has beneficial effects on NAFLD through various molecular pathways, including the activation of SIRT3, SIRT1, AMPK, and PPAR-γ, as well as the suppression of the NLRP3 pathway [251]. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.